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Abstract
The use of machine learning systems to support decision making in healthcare raises ques-
tions as to what extent these systems may introduce or exacerbate disparities in care for
historically underrepresented and mistreated groups, due to biases implicitly embedded in
observational data in electronic health records. To address this problem in the context of
clinical risk prediction models, we develop an augmented counterfactual fairness criteria
to extend the group fairness criteria of equalized odds to an individual level. We do so
by requiring that the same prediction be made for a patient, and a counterfactual patient
resulting from changing a sensitive attribute, if the factual and counterfactual outcomes
do not differ. We investigate the extent to which the augmented counterfactual fairness
criteria may be applied to develop fair models for prolonged inpatient length of stay and
mortality with observational electronic health records data. As the fairness criteria is ill-
defined without knowledge of the data generating process, we use a variational autoencoder
to perform counterfactual inference in the context of an assumed causal graph. While our
technique provides a means to trade off maintenance of fairness with reduction in predictive
performance in the context of a learned generative model, further work is needed to assess
the generality of this approach.
1. Introduction
The use of modern machine learning techniques capable of efficiently leveraging the full ex-
tent of the electronic health record (EHR) to make patient-specific predictions may provide
the means to greatly improve the quality of care and reduce costs (Goldstein et al., 2017;
Bates et al., 2014; Rajkomar et al., 2018b). Recently, concern has been raised that the
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Counterfactual Reasoning for Fair Clinical Risk Prediction
naive use of these models in routine clinical practice has the potential to reinforce existing
racial, ethnic, and socioeconomic health disparities that exist in the delivery of healthcare
in the United States (Rajkomar et al., 2018a; Char et al., 2018; Gianfrancesco et al., 2018;
Veinot et al., 2018; Cohen et al., 2014). These disparities manifest both within and be-
tween healthcare institutions, and can reflect differences in patient care, differential access
to healthcare resources, and differences in the incidence of conditions across groups (Soto
et al., 2013; Smedley et al., 2003; Mayr et al., 2010; Fowler et al., 2010; Dombrovskiy et al.,
2007; Galea et al., 2007; Pines et al., 2009). The source of this phenomenon is complex
(Chen et al., 2018; Rajkomar et al., 2018a) and related to biases implicitly encoded (Garg
et al., 2018a; Kallus and Zhou, 2018) in observational data through historical differences
in care delivery and under-representation of minority groups in the cohorts used for model
development.
In the machine learning literature, several methods of algorithmic fairness (Choulde-
chova and Roth, 2018; Suresh and Guttag, 2019) have been proposed. These methods
provide principled approaches to reasoning about and mitigating notions of bias and dis-
crimination in predictive models, but these tools remain under-explored in the context of
clinical risk prediction. Recently, Rajkomar et al. (2018a) and Goodman et al. (2018) out-
lined a taxonomy of intended and unintended sources of bias and discrimination in health-
care along with their impact and further provided a series of practical recommendations for
applying fairness constraints to machine learning models on the basis of the ethical prin-
ciples appropriate to the clinical context. In practice, measures of fairness have been used
to assess notions of inequity in the prediction of intensive care unit mortality (Chen et al.,
2018), 30-day psychiatric readmission (Chen et al., 2019), risk of atherosclerotic cardiovas-
cular disease (Pfohl et al., 2018), and for risk adjustments in health insurance markets (Zink
and Rose, 2019).
As of now, the prior work on the assessment of fairness for clinical predictive models
has focused almost exclusively on the use of group fairness metrics that assess a form of
conditional independence between model predictions, the true outcome, and membership to
a protected group on the basis of a sensitive attribute such as race, gender, or age. These
metrics are attractive because they are straightforward to reason about and verify. However,
they do not provide a meaningful assessment of fairness to individuals (Dwork et al., 2012)
or structured subgroups of protected demographic groups (Kearns et al., 2018, 2019; He´bert-
Johnson et al., 2017). That is, a model that satisfies a group fairness metric may permit
arbitrary discriminatory deviations from the criteria on subgroups or individuals as long as
the criteria are satisfied on average across the population (Kearns et al., 2018). In contrast,
counterfactual fairness (Kusner et al., 2017) is a recently proposed metric that uses tools
from causal inference to assess fairness at an individual level by requiring that a sensitive
attribute not be the cause of a change in a prediction.
In this work, we provide an interpretation of fair clinical decision making from the per-
spective of equal benefit with respect to a sensitive attribute. We show that the group
fairness notion of equalized odds (Hardt et al., 2016) has a natural interpretation within
this framework and argue for its use for a class of clinical prediction tasks. Furthermore,
we develop an augmented counterfactual fairness formulation to extend equalized odds to
the individual level. However, since evaluation of this criteria relies on untestable causal
assumptions and knowledge of the data generating process, it is generally impossible to
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reliably assess the extent to which a predictive model satisfies this criteria using observa-
tional data alone (Pearl, 2009; Imbens and Rubin, 2015; Kilbertus et al., 2017). As proof
of concept, we evaluate the fairness of predictive models of inpatient mortality and pro-
longed length of stay using EHR data and a variational autoencoder (VAE) to perform
counterfactual inference and sampling (Louizos et al., 2017; Madras et al., 2019). Within
the context of counterfactual samples drawn from the VAE, we investigate the relevant
trade-offs between predictive performance and fairness on our proposed metric.
1.1. Technical Significance
We propose an extension of counterfactual fairness (Kusner et al., 2017) and equalized odds
(Hardt et al., 2016) that we call individual equalized counterfactual odds. This metric is
motivated by clinical risk prediction, but may be of interest to the general machine learning
community for use in other applications. The algorithm we propose for developing a pre-
dictive model that satisfies this fairness metric extends counterfactual logit pairing (Garg
et al., 2018b), but relies on a VAE to simulate counterfactual samples from high dimen-
sional and sparse EHR data. Given the practical challenges associated with the empirical
evaluation of this approach, we hope that the framing we propose serves as motivation for
further empirical and theoretical work at the intersection of fairness, causal inference, and
deep generative models.
1.2. Clinical Relevance
The fairness criteria and algorithms that we propose and analyze may provide a means for
interpreting and mitigating potential biases that clinical predictive models have towards
historically disadvantaged groups. Our work formalizes group fairness in clinical risk pre-
diction with a utility theoretic framework (Heidari et al., 2019). We further introduce
counterfactual fairness to the clinical context as an alternative to the criteria that have
been applied to clinical prediction tasks thus far.
2. Background and Problem Formulation
2.1. Supervised Learning with EHR Data for Clinical Risk Prediction
Let X ∈ X = Rm be a variable designating a vector representation of coded diagnoses,
procedures, medication orders, lab results, and clinical notes derived from standard EHR
feature engineering or representation learning procedures (Reps et al., 2018; Rajkomar et al.,
2018b; Goldstein et al., 2017; Xiao et al., 2018; Miotto et al., 2016); Y ∈ Y = {0, 1} be
a binary indicator of the occurrence of a clinically relevant outcome; and A ∈ A be a
discrete indicator for a protected or sensitive attribute, such as race, ethnicity, gender, or
age. We are interested in using data D = {(xi, yi, ai)}Ni=1 ∼ p(X,Y,A) to learn a function
h(X,A) : Rm+|A| → [0, 1] approximating p(Y | X,A), which may be compared to a threshold
value T to produce predictions Yˆ (X,A) = 1[h(X,A) ≥ T ] ∈ {0, 1}.
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2.2. Utility-based Clinical Motivation for Fairness
We view the goal of fair clinical risk prediction as developing a predictive model as a
component of a clinical policy that maximizes aggregate utility, while promoting health
equity by requiring that the distribution of utility be independent of a sensitive attribute.
This aligns with the “equal benefit” definition suggested by Rajkomar et al. (2018a). A
straightforward interpretation of this criteria is it requires a clinical policy to assign the same
expected utility to a population partitioned by a sensitive attribute (for example, gender).
Depending on the clinical context motivating algorithmic fairness, it can be appropriate to
conditionally satisfy the equal benefit criteria for some collection of strata of the population
D1, . . . ,DK that intersect the groups defined by the sensitive attribute (Heidari et al., 2019).
In the most general formulation, we want for strata D1, . . . ,DK ,
Ex,y∼Dk|A=ai V (h(x, ai), y) = Ex,y∼Dk|A=aj V (h(x, aj), y)∀ ai, aj ∈ A, k ∈ {1, . . . ,K} (1)
where V denotes a utility function associated with a prediction h(x, a) and outcome y.
It is necessary to provide assumptions on the structure of policy and the individual-level
utilities induced by the predictive model if we are to relate the performance characteristics
of a predictive model to a utility-based fairness notion. To that end, we assume the expected
utility that a patient receives as a result of applying a predictor is given by
V (h(x, a), y) = 1−α0p(1[h(x, a) ≥ T ] = 1 | Y = 0)p(Y = 0 | X = x,A = a)−
α1p(1[h(x, a) ≥ T ] = 0 | Y = 1)p(Y = 1 | X = x,A = a),
(2)
for positive scalars α0 and α1 representing the costs of false positive and false negative
errors, respectively, such that vi is bounded between 0 and 1.
These assumptions have a simple interpretation such that a perfect predictor achieves
higher expected utility for each patient than any other predictor would. Furthermore,
they capture the intuition that for predictive models of adverse clinical events, it is often
undesirable to either over- or under- predict risk, as under-prediction of risk can lead to
under-management of latent disease and result in subsequent unexpected adverse events
while over-prediction of risk incurs a reduction in utility through the costs and side effects
of unnecessary treatment. We admit that this formulation is an over-simplification of clinical
decision making (Goodman et al., 2018), broadly ignoring the preferences and incentives
for relevant stakeholders, the limited capacity for intervention at the level of the health
system, heterogeneous treatment effects, and the potential for biased labels corrupted by
historical discrimination in routine care such that more accurately predicting the label in
retrospective data leads to further discrimination against the historically disadvantaged
group (Rajkomar et al., 2018a; Kallus and Zhou, 2018; Jiang and Nachum, 2019). However,
these assumptions are often implicitly made in the on-going discussion around fairness of
clinical predictive models when measures of model performance are used either as a measure
of benefit or for assessing the biases of a model (Chen et al., 2018; Rajkomar et al., 2018a;
Chen et al., 2019; Pfohl et al., 2018). We believe continued work within this framework is
valuable as long as these assumptions are critically evaluated regularly during the model
development and deployment process.
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2.3. Group Fairness
Among the fairness metrics frequently cited in the literature (Chouldechova and Roth, 2018;
Hardt et al., 2016; Calders et al., 2009; Zemel et al., 2013; Dwork et al., 2012; Kleinberg et al.,
2016; Chouldechova, 2017), that can be readily applied to a predictive model, the equalized
odds and equality of opportunity criteria (Hardt et al., 2016) are the most immediately
relevant given the formulation of equation 1. The equalized odds criteria is defined for a
specific threshold as
p(Yˆ = 1 | A = ai, Y = yk) = p(Yˆ = 1 | A = aj , Y = yk)∀ ai, aj ∈ A;∀ yk ∈ Y, (3)
and can be interpreted as requiring the same false positive rate across groups and false
negative rate across groups. Crucially, the optimal predictor satisfies equalized odds (Hardt
et al., 2016). Furthermore, it corresponds to the equal group benefit criteria in equation 1
for the utility function in equation 2 if D1 = {(x, y, a) : y = 0} and D2 = {(x, y, a) : y = 1}.
In other words, if the population is stratified on account of whether some clinical outcome Y
occurs or not, the same expected utility will be attained, on average, for patients drawn from
groups of a sensitive attribute within the strata defined by the outcome. The formulation
for equality of opportunity is similar except that data are stratified on either Y = 0 or
Y = 1, but not both.
Demographic parity (Calders et al., 2009; Zemel et al., 2013) is another fairness metric
that requires the probability of a positive prediction be the same for each group:
p(Yˆ = 1 | A = ai) = p(Yˆ = 1 | A = aj)∀ ai, aj ∈ A. (4)
We argue that this formulation is not desirable for clinical risk prediction tasks that follow
utility function 2 since it does not allow for the ideal predictor if the sensitive attribute is
correlated with the outcome (Hardt et al., 2016; Dwork et al., 2012).
2.4. Individual and Counterfactual Fairness
An alternate formulation to group fairness that is, as of yet, unexplored in medicine and
clinical risk prediction is that of individual fairness (Dwork et al., 2012). In general, this
formulation asks that “similar individuals be treated similarly” (Chouldechova and Roth,
2018), where similarity is defined by a domain-specific metric. In contrast, group-level
metrics such as equalized odds only require the criteria to hold in expectation over groups of
a sensitive attribute and thus allow for arbitrary individual-level fairness deviations (Kearns
et al., 2018).
The framework of counterfactual fairness (Kusner et al., 2017) may be interpreted as an
instance of individual fairness since it provides a means of defining a similarity metric as
well as a means of assessing fairness under that metric (Loftus et al., 2018). A necessary
component of this formulation is the availability of a structural equation model (SEM)
(Pearl, 2009) describing the causal relationships between latent background variables U
and observed variables X,A, Y through a set of functional relationships that fully govern
the data generating process. With an SEM, it is possible to reason about counterfactual
queries such as “what would the prediction have been for this patient if they belonged to a
different group?”
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That is, we can compute p(YˆA←a′(U) | X = x,A = a), the counterfactual distribution
over Yˆ corresponding to setting A = a′, given observed data X = x,A = a. Let YˆA←a′(u)
denote the value of Yˆ obtained by computing Yˆ for a fixed value of the background variable
U = u on the basis of a modified set of structural equations where A is artificially set to
a′ in all equations involving A. Then for observed data X = x and A = a, counterfactual
inference occurs by (1) computing the posterior p(U |X = x,A = a), (2) setting A = a′ to
create a modified set of structural equations, then (3) computing the implied distribution
on Yˆ given the modified equations and posterior on U . When the context is clear, we drop
the argument and denote the counterfactual by YˆA←a′ instead of YˆA←a′(u) or YˆA←a′(U).
A predictor Yˆ is then counterfactually fair if for any x ∈ X and ∀ y ∈ Y, a, a′ ∈ A:
p(YˆA←a(U) = y | X = x,A = a) = p(YˆA←a′(U) = y | X = x,A = a). (5)
The interpretation of this criterion is that it requires the same distribution of predictions
for each individual in the factual world where A = a and in each counterfactual world
where A = a′, for all a′ 6= a ∈ A. As such, it disallows a sensitive attribute to be the
cause of a change in the prediction. The individual-level distance metric that is implied by
this formulation is that individuals are treated as close to a set of matched counterfactual
individuals that share the same value for the background variables U but differ in their
membership to a group of a sensitive attribute (Loftus et al., 2018).
3. Counterfactual Reasoning for Fair Clinical Risk Prediction
3.1. Individual Equalized Counterfactual Odds
We now propose a new criterion individual equalized counterfactual odds, which is
satisfied if for all x ∈ X , a, a′ ∈ A, y ∈ Y:
p(YˆA←a(U) | X = x, YA←a = y,A = a) = p(YˆA←a′(U) | X = x, YA←a′ = y,A = a). (6)
This ensures the predictor is counterfactually fair, conditioned on the factual outcome Y
matching the counterfactual outcome YA←a′ . In contrast, the original counterfactual fair-
ness formulation can be interpreted as requiring predictions to be the same across factual-
counterfactual pairs, regardless of whether those pairs share the same value of the outcome.
To connect to our utility-based motivation for fairness, a natural desiderata is one where
the clinical policy assigns the same expected utility to each individual patient in the factual
world and in expectation over the set of counterfactual worlds where the sensitive attribute
is set to some other value. In other words, the individual’s sensitive attribute should not
be the cause of a reduction in utility relative to the utility they would receive if they
belonged to some other group of a sensitive attribute. Counterfactual fairness only implies
this property if we assume that the utility function does not depend on the outcome Y and
positive predictions are unambiguously preferred. Individual equalized counterfactual odds
may then be interpreted as requiring that this individual utility criteria hold conditioned
on holding Y constant for the factual and counterfactual individual, thus providing an
individual-level counterfactual analog to equalized odds.
Overall, we are then interested in building predictive models that:
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Figure 1: Structure of the assumed causal model. Unobserved latent variables U and sen-
sitive attribute A jointly generate the observed data X and the outcome Y .
1. For samples drawn from the factual distribution {x, y, a}, predict y as well as possible.
2. For the counterfactual samples {xA←a′ , yA←a′ , a′} predict yA←a′ as well as possible.
3. Satisfy individual equalized counterfactual odds.
3.2. Training a Fair Predictor
Now, we provide a practical training objective that can be used to develop a predictor that
satisfies the proposed criteria. We assume access to a SEM that may be used for sampling
counterfactuals with respect to a sensitive attribute. Let hθ be a black-box predictor, such
as a neural network, with parameters θ; J(hθ(x, a), y) be the cross-entropy loss; and σ
corresponds to the sigmoid function. The loss L for a sample {x, y, a} ∼ p(X,Y,A) is as
follows:
L = J(hθ(x, a), y) + λCF
∑
ak∈A
1[a 6= ak]J(hθ(xA←ak , ak), yA←ak)+
λCLP
∑
ak∈A
1[a 6= ak]1[y = yA←ak ]
(
σ−1(hθ(xA←ak , ak))− σ−1(hθ(x, a))
)2 (7)
where λCF and λCLP are scalar hyperparameters that may be used to control the relative
contribution of the three components of the loss. The first term corresponds to the loss
incurred due to errors the predictor makes on the factual sample, the second term to the
loss on the counterfactual sample, and the third term is a counterfactual logit pairing (CLP)
term (Garg et al., 2018b; Kannan et al., 2018), which is used to encourage the model to
satisfy individual equalized counterfactual odds.
3.3. Causal Effect VAE for Counterfactual Inference
Our training objective requires an SEM for performing counterfactual inference with re-
spect to a sensitive attribute. However, an SEM accurately describing the causal relation-
ships among unobserved confounders, sensitive demographic attributes, relevant clinical
outcomes, and the high-dimensional set of covariates extracted from the EHR is rarely
readily available in practice. Without additional assumptions, it is generally impossible
to infer the causal structure of the underlying data generating process directly from the
observable properties of an observational dataset (Pearl, 2009; Imbens and Rubin, 2015).
In practice, we employ a causal effect VAE (Louizos et al., 2017) to model causal effects
in the presence of unobserved confounders with observable proxies (Kuroki and Pearl, 2014;
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Miao et al., 2018; Madras et al., 2019; Wang and Blei, 2018, 2019; Tran and Blei, 2017).
Previously, Louizos et al. (2017) and Madras et al. (2019) established a sufficient condition
for causal identifiability in a related setting by requiring a well-specified causal model (i.e.
a directed acyclic graph indicating the presence and directionality of causal relationships
between variables with appropriate prior distributions on unobserved variables) and an
assumption that it is possible to estimate the true joint distribution p(X,Y,A,U) from a
finite sample observational dataset drawn from p(X,Y,A). However, as the causal graph and
parameters of interest that we consider differ from those considered in these prior works, we
make no formal guarantee of identification even in the case where these assumptions hold.
In our experiments, we assume a causal graph similar to that used in Madras et al.
(2019), depicted in Figure 1, such that X,Y are causally downstream of A and unobserved
confounders U , and that X and Y are independent conditioned on U and A.
The assumed generative process is as follows: u is drawn from an isotropic Gaussian
prior, a is drawn from a multinomial distribution with marginals pi, and x and y are drawn
from complex distributions, but are independent given a and u.
u ∼ p(U) = Normal(0, I)
a ∼ p(A) = Categorical(A | pi)
x, y ∼ p(X,Y | U,A) = p(X | U,A)p(Y | U,A).
We introduce parameterized functions pθ(x | u, a), pθ(y | u, a), and qφ(u | x, a) and learn
parameters θ, φ via the following loss function that when minimized, maximizes the lower
bound on the marginal log-likelihood (Kingma and Welling, 2013; Rezende et al., 2014):
LELBO = −Eu∼qφ(u|x,a)[log pθ(x | u, a) + log pθ(y | u, a)] +DKL(qφ(u | x, a) || p(u)). (8)
As this objective is known to permit degenerate solutions where the latent variables
contain no mutual information with the observed data (Bowman et al., 2016; Alemi et al.,
2018; Zhao et al., 2017; He et al., 2019), we employ a variant of the InfoVAE objective
(Zhao et al., 2017; Tolstikhin et al., 2018) that instead of directly maximizing the ELBO,
leverages a divergence over the aggregated posterior qφ(u), implicitly regularizing against a
loss of mutual information (Zhao et al., 2017; Kim and Mnih, 2018),
LInfoVAE = −Eu∼qφ(u|x,a)[log pθ(x | u, a) + log pθ(y | u, a)] + λD(qφ(u) || p(u)) (9)
where D is any divergence and λ is a positive scalar. Here, we choose D to be the Maximum
Mean Discrepancy (MMD) (Gretton et al., 2012) with a Gaussian radial basis function
kernel, due to the robust empirical performance of this metric in Zhao et al. (2017).
We apply an additional constraint to the loss function to encourage the approximate
posterior qφ(u | a) to be independent of a, similar to Louizos et al. (2015) and Chiappa
(2019). Overall, for a training set D we minimize a weighted version of the loss,
LCE−VAE = E(x,y,a)∼D
[
−Eu∼qφ(u|x,a) [λx log pθ(x | u, a) + λy log pθ(y | u, a)]
]
+
λMMDDMMD(qφ(u) || p(u)) + λMMDA
∑
ak∈A
DMMD(qφ(u | a = ak) || p(u)). (10)
where λx, λy, λMMD, λMMDA are scalar hyperparameters.
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Group Count Length of Stay ≥ 7 Days Inpatient Mortality
Asian 17,465 0.187 0.025
Black 5,202 0.239 0.020
Hispanic 21,978 0.196 0.019
Other 11,004 0.200 0.022
Unknown 3,593 0.201 0.072
White 70,391 0.204 0.021
Female 72,556 0.167 0.018
Male 57,076 0.245 0.029
[18, 30) 15,291 0.180 0.007
[30, 45) 27,155 0.140 0.007
[45, 65) 43,529 0.222 0.025
[65, 89) 43,658 0.226 0.036
All 129,633 0.201 0.023
Table 1: Cohort characteristics. Shown are the number of patients and incidence of pro-
longed length of stay and inpatient mortality for each race/ethnicity, gender, and
age group.
4. Methods
4.1. Cohort Construction and Labeling
We extract records from the Stanford Medicine Research Data Repository (Lowe et al.,
2009), a clinical data warehouse containing records on roughly three million patients for
clinical encounters occurring between 1990 and 2018. We extract all inpatient admissions
for patients eighteen years or older that occur in January 2010 or later with a duration
longer than 24 hours and assign an index time at 11:59 PM on the night of admission. If a
patient has more than one valid admission meeting this criteria, we randomly select one for
entry into the cohort. We consider two outcomes: (1) inpatient mortality, defined as death
prior to discharge from the hospital, and (2) prolonged length of stay (LOS), defined as a
stay lasting seven days or longer. We consider three sensitive attributes in our experiments:
(1) race/ethnicity, defined as Hispanic if ethnicity is recorded as Hispanic and the value of
the recorded race otherwise, (2) gender, recorded as male or female1, and (3) age at the
index time, discretized into four disjoint groups: 18-29, 30-44, 45-64, and 65-89 years of
age.
Statistics describing the relevant counts of patients per group and incidence of inpatient
mortality and prolonged length of stay for each group are displayed in Table 1. Notably,
of 129,633 unique patients in the final cohort, 70,391 of them are labeled as of white race,
constituting a majority; the black population has an elevated incidence of prolonged length
of stay relative to other groups; the incidence of prolonged length of stay and inpatient
mortality appears to increase with age; and a small population of patients labeled with
1. Only one patient meeting the cohort inclusion criteria was recorded with a label other than male or
female. We exclude that patient for experiments for which gender is a sensitive attribute of interest, but
include them otherwise.
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unknown race experience an elevated mortality rate. For the purposes of model development
and evaluation, the patients are randomly partitioned such that 80%, 10%, 10% are used
for training, validation, and testing, respectively.
4.2. Feature Extraction and Representation
To construct a feature representation suitable for prediction, we begin by filtering the his-
torical record for each patient for those recorded prior to the index time. We construct a
dictionary of unique clinical concepts over the set of filtered patient records by mapping
each unique historical diagnosis, procedure order, prescription, lab test order, and encounter
type to a unique token in the dictionary2. We then construct a sparse binary feature repre-
sentation for each patient by encoding each element of the dictionary as a binary attribute
indicating whether that element occurred at any point in the historical record for the pa-
tient prior to the index time. When training models to be fair with respect to a sensitive
attribute, we remove that sensitive attribute from the feature space and append all other
demographic variables not considered sensitive. The dictionary size is 368,117 features,
including all demographic variables.
4.3. Modeling and Evaluation
We conduct a series of experiments that aim to assess the practical capability for and
implication of developing clinical risk prediction models that satisfy the individual equalized
counterfactual odds criteria, when counterfactuals are sampled from a causal effect VAE
approximating the appropriate SEM. Experiments are replicated separately for each of the
three sensitive attributes (race/ethnicity, gender, and age) and the two clinical outcomes
(length of stay and inpatient mortality), for six experiments total. As a baseline, we train a
fully-connected feedforward neural network to predict each outcome using all features and
sensitive attributes as input (details in Appendix A).
For each combination of sensitive attribute and clinical outcome, we first train a causal
effect VAE to approximate the corresponding SEM (details in Appendix A). We then train
a classifier hθ to be fair with respect to the approximated SEM, by minimizing the loss in
Equation 7 with samples drawn from the corresponding VAE (details in Appendix A). We
perform a grid search over a set of hyperparameters that includes a logarithmic scale over
λCLP, λCF, and learning rates (details in Appendix B). When reporting results, we select
among these models the one that minimizes the unweighted CLP component of Equation
7 on the validation set for each unique value of λCLP. All models were developed using the
Pytorch framework (Paszke et al., 2017).
For all models, we evaluate the area under the Receiver Operating Characteristic curve
(AUC-ROC), the area under the Precision-Recall curve (AUC-PRC), and the Brier score
on the full test set as well as on the subgroups corresponding to the sensitive attribute of
interest. Additionally, for each patient in the test set, we compute the predicted probability
of the outcome produced by the predictor and compute the difference between the coun-
terfactual and factual predictions in a pairwise fashion. When conditioning on the value
2. We consider only coded clinical concepts stored in their source vocabularies, do not extract information
from clinical notes, and do not leverage numeric data such as vitals or the results of lab tests.
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Length of stay ≥ 7 Days Inpatient Mortality
λCLP AUC-PRC AUC-ROC Brier CLP AUC-PRC AUC-ROC Brier CLP
N/A 0.582 0.851 0.115 N/A 0.267 0.893 0.0206 N/A
0.0 0.56 0.843 0.12 0.0237 0.193 0.859 0.0254 0.0929
0.01 0.564 0.844 0.117 0.0106 0.192 0.856 0.025 0.0189
0.1 0.563 0.844 0.117 0.00111 0.186 0.82 0.0253 0.00456
1.0 0.563 0.845 0.117 0.000111 0.197 0.8 0.0228 0.000355
10.0 0.563 0.843 0.12 2.44e-05 0.194 0.8 0.0241 1.22e-06
Table 2: Model performance as a function of λCLP when race/ethnicity is considered as a
sensitive attribute. CLP is an aggregate measure of the extent to which a model
satisfies individual equalized counterfactual odds and is computed as the mean per
factual sample of the third term in equation 7. N/A indicates the baseline model.
λCLP
Group Metric N/A 0.0 0.01 0.1 1.0 10.0
Asian AUC-PRC 0.605 0.563 0.555 0.561 0.56 0.562
AUC-ROC 0.86 0.853 0.853 0.854 0.849 0.851
Brier 0.106 0.11 0.109 0.109 0.11 0.112
Black AUC-PRC 0.579 0.548 0.55 0.545 0.563 0.573
AUC-ROC 0.838 0.825 0.82 0.825 0.823 0.823
Brier 0.124 0.135 0.129 0.128 0.127 0.129
Hispanic AUC-PRC 0.592 0.558 0.565 0.57 0.564 0.56
AUC-ROC 0.862 0.855 0.856 0.861 0.853 0.854
Brier 0.113 0.117 0.115 0.114 0.117 0.118
Other AUC-PRC 0.549 0.557 0.557 0.563 0.553 0.561
AUC-ROC 0.824 0.827 0.819 0.824 0.819 0.827
Brier 0.122 0.124 0.121 0.121 0.122 0.124
Unknown AUC-PRC 0.675 0.616 0.616 0.606 0.614 0.633
AUC-ROC 0.9 0.891 0.888 0.893 0.891 0.887
Brier 0.104 0.106 0.103 0.103 0.105 0.111
White AUC-PRC 0.575 0.568 0.564 0.559 0.562 0.563
AUC-ROC 0.847 0.84 0.839 0.838 0.838 0.837
Brier 0.118 0.12 0.118 0.12 0.12 0.121
Table 3: Model performance for prediction of prolonged length of stay on each group as a
function of λCLP when race/ethnicity is considered as a sensitive attribute. N/A
indicates the baseline model.
of the outcome across these factual-counterfactual pairs, we obtain a measure of individ-
ual equalized counterfactual odds for each factual-counterfactual pair for each individual.
We use the mean difference for the factual-counterfactual transition across a population,
conditioned on the outcome, to assess the bias a predictor has for one group versus another.
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5. Results
For each combination of sensitive attribute (race/ethnicity, gender, age) and clinical out-
come (length of stay, inpatient mortality), we train a series of predictive models that are
penalized, to varying degrees, against individual-level deviations in the prediction logit on
the factual samples versus counterfactual samples that share the same value of the clinical
outcome. The counterfactuals are obtained on the basis of an intervention on a sensitive
attribute in a causal effect VAE trained to approximate the data generating process.
In the interest of brevity, in the main text, we present results corresponding to the
prolonged length of stay outcome with race/ethnicity treated as the sensitive attribute.
Results for other sensitive attributes (age, gender) as well as for combinations of those
attributes with the mortality outcome are provided in Appendix C and D.
5.1. Baseline Model Performance
In this section, we discuss aggregate performance of the baseline model (a feed-forward
neural network including all sensitive attributes). We will later compare to these results
when discussing the models developed to satisfy individual equalized counterfactual odds.
For prolonged length of stay the baseline model attains an AUC-PRC of 0.582, an
AUC-ROC of 0.851, and a Brier score of 0.115 (Table 2). For inpatient mortality the
baseline model attains an AUC-PRC of 0.267, an AUC-ROC of 0.893, and a Brier score of
0.0206. We note that the model exhibits disparate performance across subgroups defined
by each sensitive attribute. Across subgroups defined by race/ethnicity, the model for
prolonged length of stay generally performs comparably across the subgroups, with the
worst performance on the group labeled as “Other” (AUC-PRC of 0.549 and AUC-ROC of
0.862) and the best performance for the group labeled as “Unknown” (AUC-PRC of 0.675
and AUC-ROC of 0.90). Across subgroups defined by gender, the model for prolonged
length of stay exhibits lower AUC-ROC and worse calibration for the male population
(Table C.3). Across subgroups defined by age, the model for prolonged length of stay
exhibits lower AUC-ROC and worse calibration as age increases (Table C.4). For the model
of inpatient mortality, results are more variable across groups (Table C.5, C.6, C.7), likely
due to the lower prevalence of positive labels.
5.2. Trade-offs in Fairness
For models of prolonged length of stay, we observe that the aggregate model performance
does not appear to degrade as a function of λCLP, although there does appear to be a
fixed minor reduction in AUC-ROC and AUC-PRC for each of these models relative to
the baseline (Table 3). However, for models that predict inpatient mortality, we observe
more significant trade-offs in terms of reduced AUC-ROC and AUC-PRC at higher levels of
λCLP (Table C.5). These trends are generally reproduced for each subgroup in terms of the
relative changes in the aggregate performance measures for each subgroup over the range
of λCLP (Table 3, C.5) relative to the subgroup-level baseline.
When the mean difference between counterfactual and factual predictions conditioned on
an equal factual-counterfactual outcome are computed in a pairwise fashion between all pairs
of groups, we attain an aggregate measure indicating to what extent a predictor satisfies
12
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Figure 2: Mean difference in the counterfactual versus factual predicted probability of a
length of stay greater than or equal to seven days conditioned on the outcome
not occurring across race/ethnicity factual-counterfactual pairs. Positive values
indicate a larger value for the counterfactual relative to the factual prediction.
individual equalized counterfactual odds. Furthermore, the directionality and magnitude of
these differences for models trained with λCLP = 0 gives a measure of bias that a predictive
model developed with standard procedures may have towards a group. For instance, in
the case that λCLP = 0, we observe that the mean predicted probability of a prolonged
length of stay is reduced for black patients for transitions to any other counterfactual
group, conditioned on the outcome not changing in the counterfactual (Figures 2, 3). We
see that the opposite is true as well in that, on average, counterfactual transitions from
any group towards a black counterfactual race/ethnicity leads to an increased prediction of
prolonged length of stay conditioned on the length of stay being the same for the factual-
counterfactual pair. In other experiments, the inpatient mortality prediction model shows
qualitatively similar behavior on the “Unknown” race/ethnicity group (Figures D.1, D.2).
We find that our approach appears to be capable of mitigating these differences, as the
relative magnitude of these differences greatly reduces for modest values of λCLP.
6. Discussion
In this work, we develop an individual-level analogue to the equalized odds criterion using
the counterfactual fairness framework and provide a practical algorithm applied to EHR
data that leverages a causal effect VAE to perform counterfactual inference. We empirically
evaluate this approach and show that we can produce predictive models of prolonged length
of stay that achieve fairness with respect to individual equalized counterfactual odds, in the
context of the learned generative model, with only minor reductions in aggregate perfor-
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Figure 3: Mean difference in the counterfactual versus factual predicted probability of a
length of stay greater than or equal to seven days conditioned on the outcome
occurring across race/ethnicity factual-counterfactual pairs. Positive values in-
dicate a larger value for the counterfactual relative to the factual prediction.
mance metrics. However, we find that these trade-offs are more severe for models that
predict inpatient mortality.
6.1. Related Causally-Motivated Fairness Frameworks
Our formulation of individual equalized counterfactual odds is connected to several other
causally-motivated techniques for measuring fairness. The most related is the metric pro-
posed in Ritov et al. (2017), which bears similarity to equation 6 except that it does not
condition on X = x. Our work is also related to a series of works that define path-specific
measures of fairness (Nabi and Shpitser, 2018; Chiappa, 2019; Kilbertus et al., 2017), which
can be interpreted as a relaxation of counterfactual fairness where fairness is only enforced
through pre-defined paths in a causal graph. Zhang and Bareinboim (2018) explore the
use of graphical causal explanation techniques to provide an alternative notion of a causal
analogue to equalized odds and equality of opportunity that allows for potential sources of
bias to be decomposed into interpretable components. Finally, the formulation of the VAE
we use for counterfactual inference is inspired by the work of Madras et al. (2019), who
use a similar causal diagram and model architecture to estimate heterogeneous treatment
effects by treating sensitive attributes as causally upstream of observed data.
6.2. Fairness and Utility
While we motivate our work on the basis of clinical contexts for which individual- and group-
notions of equalized odds are appropriate measures of fairness due to a correspondence be-
tween these measures to equitable utility maximization, this formulation is only appropriate
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under the strong assumptions that we place on the structure of the utility function and pol-
icy implied by the predictive model. It should be emphasized that other commonly cited
measures of group fairness, including demographic parity (Calders et al., 2009; Zemel et al.,
2013; Dwork et al., 2012) and predictive value parity (Chouldechova, 2017; Kleinberg et al.,
2016; Heidari et al., 2019) can also be cast in the equal benefit framework we describe here
if appropriate conditioning sets and a utility function consistent with the clinical context
are specified. For instance, if it is assumed that all patients prefer a positive prediction and
the utility function does not depend on the outcome Y , then demographic parity (Calders
et al., 2009; Zemel et al., 2013) is appropriate. Furthermore, in cases where clinicians have
limited capacity to intervene and dismissal bias or alert fatigue are a concern (Rajkomar
et al., 2018a), it may be more appropriate to design fairness criteria around equalizing the
positive and negative predictive values or calibration across groups (Kleinberg et al., 2016;
Chouldechova, 2017; Heidari et al., 2019).
6.3. Causal Identifiability and the VAE
A limitation of our approach is the reliance on a VAE to perform counterfactual inference for
observational datasets when an SEM is not available, as it is generally impossible to verify
the assumptions sufficient for identification of the relevant causal effects (Louizos et al., 2017;
Kilbertus et al., 2017; Madras et al., 2019). Without identification, a counterfactual fairness
criteria that relies on a learned generative model for counterfactual sampling, including the
original formulation of Kusner et al. (2017) and individual equalized counterfactual odds, is
only well-defined in the context of the generative model, which may differ arbitrarily from
the true data generating process as long as the corresponding observational distributions
match. It is thus possible that a predictive model deemed fair on the basis of individual
equalized counterfactual odds may in truth be unfair with respect to the true data generating
process. In future work, we plan to investigate the use of sensitivity analyses (Franks et al.,
2019; D’Amour, 2019) and simulation studies to explore the effect that these considerations
have on the the procedure we propose.
7. Conclusion
We build off of recent efforts to formalize notions of algorithmic fairness for clinical decision
support systems based on predictive models. In doing so, we propose a novel counterfactual
fairness measure called individual equalized counterfactual odds and argue for its use for a
class of clinical risk prediction problems where it is of interest to produce accurate predictive
models that are fair to individuals. Empirically, the training procedure we propose is capable
of producing fair clinical risk prediction models from EHR data with respect to individual
equalized counterfactual odds computed on the basis of counterfactuals sampled from a
learned generative model, but further work is needed to characterize the robustness and
consistency of our approach.
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Appendix A. Additional Training Details
A.1. Baseline Predictor
We construct a fully-connected neural network with fixed size per layer as a baseline predic-
tor for each outcome. We consider the number of layers, the size of each layer, the learning
rate, the dropout probability, and the use of layer normalization as hyperparameters. For
each outcome, we select the model that minimizes the validation loss over one hundred
iterations of random search. The selected hyperparameters are shown in Table B.1.
A.2. Causal Effect VAE
For each sample {x, y, a}, the amortized inference model qφ(u | x, a) maps from the sparse
and high dimensional input to the parameters of a Gaussian {µ, σ} with diagonal covariance
and the reparameterization trick (Kingma and Welling, 2013) is used to draw a single sample
u. In the latent space, we embed and concatenate a to u as input to the decoders pθ(y | u, a)
and pθ(x | u, a). As the data X are binary and we model pθ(x | u, a) with components
conditionally independent given u and a, we perform maximum likelihood in this model
by minimizing a mean dimension-wise cross-entropy loss over the elements of pθ(x | u, a)
and by minimizing a binary cross-entropy loss for the prediction pθ(y | u, a). The MMD
terms are computed by considering the N samples {uj ∼ qφ(ui | xi, ai)}Ni=1 drawn during a
mini-batch as samples from qφ(U) (Zhao et al., 2017). The samples from qφ(U | a) are taken
as the subset of those drawn from the batch that correspond to A = a. As is suggested by
Zhao et al. (2017), we fix the λ values in the loss such that each term is of the same order
of magnitude.
The architectural hyperparameters of this model are selected on the basis of minimiza-
tion of the weighted loss on the validation set over one hundred iterations of random search
and are selected separately for each combination of sensitive attribute and clinical outcome.
The selected hyperparameters as shown in Table B.2.
A.3. Fair Predictor
The fair predictor is trained with the objective given by equation 7. The model architecture
for the fair predictor is fixed to match that of the predictive component of the VAE, pθ(y |
u, a), and the weights are randomly intitialized. Since the training objectives requires
counterfactual outcomes yA←a′ , for each sample {x, y, a} we randomly sample a single u ∼
qφ(u|x, y, a) and yA←a′ ∼ pθ(y | u, a′) for all a′ 6= a at both training and evaluation time.
In practice, we leverage a modified objective where the predictor hθ takes u and a as
input, rather than x and a. Counterfactual predictions are then made on the basis of
hθ(u, a
′) rather than hθ(xA←a′ , a′). For computing the CLP, rather than using the inverse
sigmoid of the predicted probabilities of a positive outcome, we take the mean over the
element-wise squared differences in the two-dimensional pre-softmax logits produced by the
predictor.
Relevant hyperparameters include λCLP, λCF, and an additional hyperparameter CF-
Gradients which, when true, indicates whether gradients are propagated through the coun-
terfactual samples in the CLP term of equation 7. As previously indicated, we perform a
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grid search and select the model that minimizes the CLP component of the loss in equa-
tion 7 for a fixed value of λCLP across the grid of other hyperparameters. The selected
hyperparameters are shown in Table B.3.
Appendix B. Hyperparameters
Parameter Length of Stay ≥ 7 Days Inpatient Mortality
Batch Size 512 512
Dropout Probability 0.5 0.75
Hidden Dimension 128 128
Learning Rate 0.00001 0.0001
Layer Normalization True True
Number of Hidden Layers 3 2
Table B.1: Selected hyperparameters for the baseline predictor by outcome
Length of Stay ≥ 7 Days Inpatient Mortality
Age Gender Race/Ethnicity Age Gender Race/Ethnicity
Batch Size 512 512 512 512 512 512
Dropout Probability VAE 0.25 0.25 0.75 0 0.25 0
Dropout Probability Predictor 0.25 0.25 0.5 0.5 0.25 0.5
Group Embedding Dimension 64 64 32 64 64 64
Hidden Dimension Predictor 128 128 256 256 128 256
λy 10 10 10 10 10 10
λMMD 10000 10000 10000 10000 10000 10000
λMMDA 1000 1000 1000 1000 1000 1000
λx 1000 1000 1000 1000 1000 1000
Latent Dimension 128 128 128 128 128 128
Learning Rate 0.0001 0.0001 0.001 0.001 0.0001 0.001
Layer Normalization VAE False False True True False True
Layer Normalization Predictor True True True True True True
Number of Hidden Layers VAE 1 1 2 1 1 1
Number of Hidden Layers Predictor 2 2 2 2 2 2
Table B.2: Selected hyperparameters for the VAE by outcome and sensitive attribute.
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Outcome Sensitive Attribute λCLP CF-Gradients λCF Learning Rate
Length of Stay ≥ 7 Days Age 0.00 True 0.1 0.0001
0.01 True 0.0 0.0100
0.10 True 0.0 0.0100
1.00 True 0.0 0.0100
10.00 False 0.0 0.0100
Gender 0.00 False 0.1 0.0100
0.01 True 0.1 0.0010
0.10 True 0.0 0.0010
1.00 True 0.0 0.0100
10.00 True 0.1 0.0010
Race/Ethnicity 0.00 False 10.0 0.0100
0.01 True 0.1 0.0100
0.10 True 0.0 0.0010
1.00 True 0.0 0.0010
10.00 True 1.0 0.0100
Inpatient Mortality Age 0.00 False 0.0 0.0100
0.01 False 0.0 0.0100
0.10 True 0.0 0.0010
1.00 True 0.1 0.0010
10.00 True 0.0 0.0010
Gender 0.00 True 10.0 0.0100
0.01 True 0.1 0.0100
0.10 True 0.0 0.0010
1.00 True 1.0 0.0100
10.00 True 0.1 0.0010
Race/Ethnicity 0.00 True 10.0 0.0100
0.01 True 1.0 0.0100
0.10 True 0.0 0.0100
1.00 True 0.0 0.0001
10.00 True 0.1 0.0010
Table B.3: Selected hyperparameters for the models trained to be fair with respect to indi-
vidual equalized counterfactual odds by outcome, sensitive attribute, and λCLP.
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Appendix C. Supplementary Tables
Length of Stay ≥ 7 Days Inpatient Mortality
λCLP AUC-PRC AUC-ROC Brier CLP AUC-PRC AUC-ROC Brier CLP
N/A 0.582 0.851 0.115 N/A 0.267 0.893 0.0206 N/A
0.0 0.563 0.84 0.118 0.0999 0.218 0.879 0.0207 0.0363
0.01 0.567 0.841 0.119 0.0335 0.208 0.868 0.0208 0.000355
0.1 0.568 0.842 0.118 0.00426 0.208 0.871 0.0207 7.12e-05
1.0 0.56 0.839 0.118 5e-05 0.203 0.872 0.0209 3.37e-06
10.0 0.558 0.835 0.134 9.82e-06 0.0772 0.76 0.0241 1.04e-07
Table C.1: Model performance as a function of λCLP when gender is considered as a sen-
sitive attribute. CLP is an aggregate measure of the extent to which a model
satisfies individual equalized counterfactual odds and is computed as the mean
per factual sample of the third term in equation 7. N/A indicates the baseline
model.
Length of Stay ≥ 7 Days Inpatient Mortality
λCLP AUC-PRC AUC-ROC Brier CLP AUC-PRC AUC-ROC Brier CLP
N/A 0.582 0.851 0.115 N/A 0.267 0.893 0.0206 N/A
0.0 0.542 0.822 0.125 0.107 0.203 0.869 0.024 0.223
0.01 0.555 0.836 0.122 0.0398 0.187 0.829 0.024 0.0191
0.1 0.555 0.836 0.122 0.0104 0.183 0.823 0.022 0.0055
1.0 0.555 0.836 0.119 0.00027 0.202 0.822 0.0225 0.000237
10.0 0.564 0.835 0.121 1.99e-05 0.162 0.81 0.0243 8.73e-07
Table C.2: Model performance as a function of λCLP when age is considered as a sensi-
tive attribute. CLP is an aggregate measure of the extent to which a model
satisfies individual equalized counterfactual odds and is computed as the mean
per factual sample of the third term in equation 7. N/A indicates the baseline
model.
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λCLP
Group Metric N/A 0.0 0.01 0.1 1.0 10.0
Female AUC-PRC 0.564 0.529 0.544 0.539 0.534 0.541
AUC-ROC 0.864 0.853 0.854 0.856 0.855 0.848
Brier 0.0993 0.102 0.104 0.103 0.101 0.116
Male AUC-PRC 0.597 0.587 0.59 0.593 0.584 0.589
AUC-ROC 0.829 0.815 0.818 0.817 0.822 0.82
Brier 0.136 0.14 0.141 0.14 0.138 0.155
Table C.3: Model performance for prediction of prolonged length of stay on each group
as a function of λCLP when gender is considered as a sensitive attribute. N/A
indicates the baseline model.
λCLP
Group Metric N/A 0.0 0.01 0.1 1.0 10.0
[18, 30) AUC-PRC 0.608 0.548 0.581 0.597 0.611 0.597
AUC-ROC 0.885 0.84 0.868 0.869 0.875 0.87
Brier 0.098 0.11 0.106 0.104 0.0992 0.103
[30, 45) AUC-PRC 0.545 0.515 0.532 0.531 0.549 0.546
AUC-ROC 0.882 0.852 0.869 0.864 0.871 0.867
Brier 0.087 0.0925 0.0941 0.0923 0.0884 0.0895
[45, 65) AUC-PRC 0.606 0.554 0.562 0.575 0.579 0.591
AUC-ROC 0.849 0.816 0.834 0.838 0.839 0.839
Brier 0.123 0.135 0.133 0.129 0.126 0.129
[65, 89) AUC-PRC 0.564 0.537 0.525 0.534 0.533 0.556
AUC-ROC 0.817 0.79 0.803 0.802 0.804 0.807
Brier 0.131 0.142 0.14 0.139 0.137 0.136
Table C.4: Model performance for prediction of prolonged length of stay on each group
as a function of λCLP when age is considered as a sensitive attribute. N/A
indicates the baseline model.
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λCLP
Group Metric N/A 0.0 0.01 0.1 1.0 10.0
Asian AUC-PRC 0.238 0.192 0.179 0.206 0.207 0.133
AUC-ROC 0.9 0.848 0.849 0.827 0.815 0.813
Brier 0.0217 0.0255 0.0254 0.0247 0.0237 0.0248
Black AUC-PRC 0.275 0.152 0.253 0.166 0.185 0.303
AUC-ROC 0.899 0.878 0.862 0.872 0.87 0.89
Brier 0.0153 0.0221 0.022 0.0244 0.0181 0.0185
Hispanic AUC-PRC 0.327 0.272 0.281 0.27 0.274 0.284
AUC-ROC 0.913 0.871 0.868 0.856 0.818 0.831
Brier 0.0202 0.0237 0.0228 0.0233 0.0219 0.0242
Other AUC-PRC 0.407 0.153 0.158 0.248 0.233 0.288
AUC-ROC 0.932 0.849 0.849 0.859 0.842 0.844
Brier 0.0137 0.0223 0.0206 0.0216 0.0171 0.018
Unknown AUC-PRC 0.683 0.603 0.596 0.514 0.572 0.55
AUC-ROC 0.964 0.947 0.95 0.919 0.9 0.898
Brier 0.0367 0.0481 0.0493 0.049 0.0425 0.0559
White AUC-PRC 0.183 0.136 0.143 0.137 0.137 0.135
AUC-ROC 0.869 0.84 0.837 0.791 0.764 0.768
Brier 0.0209 0.0259 0.0255 0.0257 0.023 0.0235
Table C.5: Model performance for prediction of inpatient mortality on each group as a
function of λCLP when race/ethnicity is considered as a sensitive attribute.
N/A indicates the baseline model.
λCLP
Group Metric N/A 0.0 0.01 0.1 1.0 10.0
Female AUC-PRC 0.289 0.235 0.215 0.201 0.223 0.0653
AUC-ROC 0.924 0.92 0.906 0.912 0.907 0.788
Brier 0.016 0.0159 0.0161 0.0163 0.0159 0.0194
Male AUC-PRC 0.255 0.23 0.216 0.231 0.205 0.0807
AUC-ROC 0.854 0.85 0.836 0.851 0.829 0.725
Brier 0.0264 0.0267 0.0267 0.0263 0.0268 0.0301
Table C.6: Model performance for prediction of inpatient mortality on each group as
a function of λCLP when gender is considered as a sensitive attribute. N/A
indicates the baseline model.
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λCLP
Group Metric N/A 0.0 0.01 0.1 1.0 10.0
[18, 30) AUC-PRC 0.0507 0.0589 0.052 0.0582 0.0516 0.023
AUC-ROC 0.83 0.807 0.642 0.675 0.629 0.836
Brier 0.00565 0.00684 0.00698 0.00606 0.00662 0.00831
[30, 45) AUC-PRC 0.333 0.241 0.208 0.242 0.236 0.21
AUC-ROC 0.97 0.907 0.943 0.912 0.907 0.883
Brier 0.00483 0.00502 0.00546 0.00505 0.00558 0.00833
[45, 65) AUC-PRC 0.33 0.199 0.194 0.207 0.21 0.179
AUC-ROC 0.906 0.874 0.881 0.861 0.876 0.853
Brier 0.0208 0.0266 0.0261 0.0228 0.0239 0.0254
[65, 89) AUC-PRC 0.258 0.223 0.219 0.22 0.23 0.212
AUC-ROC 0.84 0.813 0.802 0.799 0.804 0.795
Brier 0.0353 0.0404 0.0402 0.037 0.0386 0.0389
Table C.7: Model performance for prediction of inpatient mortality on each group as a
function of λCLP when age is considered as a sensitive attribute. N/A indicates
the baseline model.
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Appendix D. Supplementary Figures
Figure D.1: Mean difference in the counterfactual versus factual predicted probability of
inpatient mortality conditioned on the outcome not occurring across
race/ethnicity factual-counterfactual pairs. Positive values indicate a larger
value for the counterfactual relative to the factual prediction.
Figure D.2: Mean difference in the counterfactual versus factual predicted probability
of inpatient mortality conditioned on the outcome occurring across
race/ethnicity factual-counterfactual pairs. Positive values indicate a larger
value for the counterfactual relative to the factual prediction.
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Figure D.3: Mean difference in the counterfactual versus factual predicted probability of a
length of stay greater than or equal to seven days conditioned on the outcome
not occurring across gender factual-counterfactual pairs. Positive values
indicate a larger value for the counterfactual relative to the factual prediction.
Figure D.4: Mean difference in the counterfactual versus factual predicted probability of a
length of stay greater than or equal to seven days conditioned on the outcome
occurring across gender factual-counterfactual pairs. Positive values indicate
a larger value for the counterfactual relative to the factual prediction.
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Figure D.5: Mean difference in the counterfactual versus factual predicted probability of
inpatient mortality conditioned on the outcome not occurring across gen-
der factual-counterfactual pairs. Positive values indicate a larger value for the
counterfactual relative to the factual prediction.
Figure D.6: Mean difference in the counterfactual versus factual predicted probability of
inpatient mortality conditioned on the outcome occurring across gender
factual-counterfactual pairs. Positive values indicate a larger value for the
counterfactual relative to the factual prediction.
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Figure D.7: Mean difference in the counterfactual versus factual predicted probability of a
length of stay greater than or equal to seven days conditioned on the out-
come not occurring across age factual-counterfactual pairs. Positive values
indicate a larger value for the counterfactual relative to the factual prediction.
Figure D.8: Mean difference in the counterfactual versus factual predicted probability of a
length of stay greater than or equal to seven days conditioned on the outcome
occurring across age factual-counterfactual pairs. Positive values indicate a
larger value for the counterfactual relative to the factual prediction.
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Figure D.9: Mean difference in the counterfactual versus factual predicted probability of
inpatient mortality conditioned on the outcome not occurring across age
factual-counterfactual pairs. Positive values indicate a larger value for the
counterfactual relative to the factual prediction.
Figure D.10: Mean difference in the counterfactual versus factual predicted probability of
inpatient mortality conditioned on the outcome occurring across age
factual-counterfactual pairs. Positive values indicate a larger value for the
counterfactual relative to the factual prediction.
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